Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04417218 · ClinicalTrials.gov registry record · NA
Determinants of Alpha-aminoadipic Acid (2-AAA) and Relationship to Diabetes: Study 2
A NA study, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 67
- Enrollment target
NCT04417218 is a NA study that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 67 participants.
The verdict
NCT04417218, a NA study, has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 67 participants
- Enrollment target
Study Summary
This study aims to assess the effect of controlled dietary lysine intake on plasma and urine α-aminoadipic acid (2-AAA).
Interventions
- DIETARY_SUPPLEMENT Lysine
- DIETARY_SUPPLEMENT Controlled Diet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 67 participants |
| Start Date | 2020-08-17 |
| Est. Completion | 2023-01-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04417218
The ClinicalTrials.gov registry entry for NCT04417218 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 67 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Lysine is the first listed.
NCT04417218 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04417218 about?
NCT04417218 is a clinical study titled "Determinants of Alpha-aminoadipic Acid (2-AAA) and Relationship to Diabetes: Study 2". This study aims to assess the effect of controlled dietary lysine intake on plasma and urine α-aminoadipic acid (2-AAA).
What is the current status of trial NCT04417218?
This trial is currently completed. It is a NA study. The enrollment target is 67 participants. The study started on 2020-08-17. Estimated completion is 2023-01-01.
What interventions are being tested in trial NCT04417218?
The interventions under investigation include: Lysine (DIETARY_SUPPLEMENT), Controlled Diet (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04417218?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.